The laboratory director was pressured to defend the company's findings against the doctors.
According to him, company executives are reluctant to test the skills required by federal law so that clinical laboratories can test patient samples. This and a number of other problems caused him to lose faith in the company. “I came to think the company was more about PR and fundraising than about patients,” Rosendorf said. Rezndorf did not always have such a dark view of Tranos. When she joined the company in April 2013, she was eager to help founder Elizabeth Holmes understand her vision of replacing venous blood with a wand.
"I thought Theranos had advanced technology that would allow them to do that." "I thought Apple would be next." However, within a few months, he doubted Tranos' ability to do what he hoped to do, and in the summer of that year he was looking for a new job. Metis tells the court that Elizabeth Holmes was "responsible" at Trannos, Tranos was due to begin diagnostic tests for patients on September 9, 2013, and as that date approaches, Reisendorff said it "sounds the alarm." As of August 31, a few weeks before launch, none of the company's tests had been approved by law, and emails indicate that Holmes was aware of the problem. Reisendorff lobbied Holmes and Ramesh "Sunny" Palvani, the company's president and chief operating officer, to cancel the public launch in order to resolve issues with employee testing and training. He called for "a few more weeks to resolve these medical and logistical issues." Rezndorf said he did not feel that his supervisor, Balvani, was taking him seriously, so he met directly with Holmes to press for a postponement. "It was very tense," he said of the meeting. "He wasn't improving his usual self. He was shivering a little." "This case has already been resolved"
At some point, Theranos used its Edison device to test patient samples, and results were often inconsistent or disturbing. I heard that one of his patients had his hCG sent to Tranos in October 2014 for a major pregnancy hormone test.
The first result was 12558, much higher than expected given the stage The second result was 125.58, so low that the nurse was afraid the woman would have an abortion. At the time of the woman's pregnancy test, Holmes was aware of the diagnosis. In June 2014, Holmes' brother, Christine, of fyi-hCG, who acted as a liaison between the doctors and the lab manager, sent an email to him and to Palvani, saying, "Currently, fyi-hCG is causing serious problems and patient complaints." p>
Holmes responded by saying "It has already been done," he told Palvani. In fact, he told the court that this was the first time he had seen them.
Other Suspicious Tests h2>
Theranos also showed suspicious results for HDL cholesterol, sodium and potassium. , and their chloride was sometimes well below the acceptable range, which Rosendorf himself suspected of having problems in the experiments. In February 2014, he proposed transferring patient tests to third-party devices. He said that Holmes, Balvani and the CEO no longer want to make the change. "I got a lot of pressure."Advertising
Instead of telling health care providers that they have problems with tests, Tranos cancels results that are above or below acceptable values. For some patients, this exercise was a problem. In one example, a doctor ordered a test for a patient with low sodium, and the test results were so low that the practice of tranos was to throw them out. The customer service representative assigned to the case was not sure how to proceed and emailed R ndorff: "Could this be the amount? If he re-enters, and the value is still too low, will it be invalidated again?"? p>
If a doctor suspects a patient has hyponatremia, they will have a lab test to confirm it. He could have acted accordingly, but Tranos refuted the very low test results - even if the results were accurate. The act of emptying the results provokes Out of bounds Questions that can be trusted, if any.R nd Zendorff wrote to Balvani and Holmes: "Clinical value of sodium, in which we can report only when not critical, and cases requiring careful measurement and report of abnormal sodium findings are excluded." Emailing a customer service representative
from Rosendorf's testimony, and through emails provided by the attorney general, it is clear that Holmes was not only aware of the many issues with the Tranos test, but was directing the response.< p> As Tranos' problems continued, and when Rosendorf pressured himself to defend the company's findings for doctors, he began sending emails to his personal Gmail account. "I wanted to protect myself," he told the court.
Emails show Elizabeth Holmes responding to the failed Theranos trials
Four days ago, the ransomware website REvil, better known as "...
There is a saying in the startup world that many companies are trying to sh...
Last month, Intel CEO Pat Gelsinger took to the podium on a foggy and win...